Identification and Structure–Activity Relationships of Novel Compounds that Potentiate the Activities of Antibiotics in Escherichia coli
Journal Article
·
· Journal of Medicinal Chemistry
- Saint Louis Univ., St. Louis, MO (United States). School of Medicine. Dept. of Pharmacological and Physiological Science
- Univ. of Oklahoma, Norman, OK (United States). Dept. of Chemistry and Biochemistry
- Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States). Biosciences Division. UT/ORNL Center for Molecular Biophysics; Univ. of Tennessee, Knoxville, TN (United States). Graduate School of Genome Science and Technology
- Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States). Biosciences Division. UT/ORNL Center for Molecular Biophysics; Univ. of Tennessee, Knoxville, TN (United States). Dept. of Biochemistry and Cellular and Molecular Biology
- Saint Louis Univ., St. Louis, MO (United States). School of Medicine. Dept. of Pharmacological and Physiological Science. Dept. of Chemistry
In Gram-negative bacteria, efflux pumps are able to prevent effective cellular concentrations from being achieved for a number of antibiotics. Small molecule adjuvants that act as efflux pump inhibitors (EPIs) have the potential to reinvigorate existing antibiotics that are currently ineffective due to efflux mechanisms. Through a combination of rigorous experimental screening and in silico virtual screening, we recently identified novel classes of EPIs that interact with the membrane fusion protein AcrA, a critical component of the AcrAB-TolC efflux pump in Escherichia coli. In this paper, we present initial optimization efforts and structure–activity relationships around one of those previously described hits, NSC 60339 (1). Finally, from these efforts we identified two compounds, SLUPP-225 (17h) and SLUPP-417 (17o), which demonstrate favorable properties as potential EPIs in E. coli cells including the ability to penetrate the outer membrane, improved inhibition of efflux relative to 1, and potentiation of the activity of novobiocin and erythromycin.
- Research Organization:
- Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States); Saint Louis Univ., St. Louis, MO (United States); Univ. of Oklahoma, Norman, OK (United States)
- Sponsoring Organization:
- National Inst. of Health (NIH) (United States); USDOE; Univ. of Saint Louis School of Medicine (United States)
- Contributing Organization:
- Univ. of Tennessee, Knoxville, TN (United States)
- Grant/Contract Number:
- AC05-00OR22725
- OSTI ID:
- 1376432
- Journal Information:
- Journal of Medicinal Chemistry, Journal Name: Journal of Medicinal Chemistry Journal Issue: 14 Vol. 60; ISSN 0022-2623
- Publisher:
- American Chemical Society (ACS)Copyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Discovery of multidrug efflux pump inhibitors with a novel chemical scaffold
Mechanistic Duality of Bacterial Efflux Substrates and Inhibitors: Example of Simple Substituted Cinnamoyl and Naphthyl Amides
Journal Article
·
Mon Feb 03 19:00:00 EST 2020
· Biochimica et Biophysica Acta - General Subjects
·
OSTI ID:1606783
Mechanistic Duality of Bacterial Efflux Substrates and Inhibitors: Example of Simple Substituted Cinnamoyl and Naphthyl Amides
Journal Article
·
Tue Aug 10 20:00:00 EDT 2021
· ACS Infectious Diseases
·
OSTI ID:1820794